Clinical trial
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in…
NCT00005663 · Glaxo Wellcome, Industry · Unknown status
Key facts
| NCT number | NCT00005663 |
|---|---|
| Title | A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients |
| Official title | An International, Randomized, Double-Blind, Placebo-Controlled Study of Valacyclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects |
| Lead sponsor | Glaxo Wellcome, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Simplex, HIV Infections, Herpes Genitalis |
| Intervention type | Drug |
| Interventions | Valacyclovir hydrochloride |
| Start date | Jun 1, 1999 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: